Treatment Strategy for Rifampin-Susceptible Tuberculosis. Reply
- PMID: 37314717
- DOI: 10.1056/NEJMc2304776
Treatment Strategy for Rifampin-Susceptible Tuberculosis. Reply
Comment on
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Mar 9;388(10):873-887. doi: 10.1056/NEJMoa2212537. Epub 2023 Feb 20. N Engl J Med. 2023. PMID: 36808186 Free PMC article. Clinical Trial.
Similar articles
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Jun 15;388(24):2297-2298. doi: 10.1056/NEJMc2304776. N Engl J Med. 2023. PMID: 37314716 No abstract available.
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Jun 15;388(24):2297. doi: 10.1056/NEJMc2304776. N Engl J Med. 2023. PMID: 37314715 No abstract available.
-
Treatment Strategy for Rifampin-Susceptible Tuberculosis.N Engl J Med. 2023 Jun 15;388(24):2296-2297. doi: 10.1056/NEJMc2304776. N Engl J Med. 2023. PMID: 37314714 No abstract available.
-
Rifampin.Tuberculosis (Edinb). 2008 Mar;88(2):151-4. doi: 10.1016/S1472-9792(08)70024-6. Tuberculosis (Edinb). 2008. PMID: 18486058 Review. No abstract available.
-
Rifampin.Pediatr Rev. 2004 Jun;25(6):216-7. doi: 10.1542/pir.25-6-216. Pediatr Rev. 2004. PMID: 15173456 Review. No abstract available.
Cited by
-
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.Genome Med. 2024 Feb 19;16(1):34. doi: 10.1186/s13073-024-01289-5. Genome Med. 2024. PMID: 38374151 Free PMC article.
-
Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies.Expert Rev Anti Infect Ther. 2023 Jun;21(6):595-616. doi: 10.1080/14787210.2023.2207820. Epub 2023 May 8. Expert Rev Anti Infect Ther. 2023. PMID: 37128947 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical